Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)
ID: 332514Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $50K

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/332514

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PA-21-199.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for research on Autism Spectrum Disorders (ASD) through the R03 Clinical Trial Optional grant program. This initiative aims to support small, well-defined research projects focused on the etiology, epidemiology, diagnosis, and service delivery related to ASD, with grants designed to be completed within two years and requiring limited resources. The total funding available is capped at $100,000 over two years, with a maximum of $50,000 per year, and applications will be evaluated based on significance, innovation, and approach, among other criteria. Interested applicants must submit their proposals by November 16, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance with the application process.

    Point(s) of Contact
    FBOWebmaster@OD.NIH.GOV
    Files
    Title
    Posted
    PA-21-199-Full-Announcement.html
    PA-21-199.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is offering funding opportunities under the Research on Autism Spectrum Disorders (ASD) initiative, specifically targeting small grant applications (R03 Clinical Trial Optional). The primary objective is to support research on ASD's etiology, epidemiology, diagnosis, and service delivery, with grants designed for small, well-defined projects that can be completed within two years and require limited resources. Eligible applicants include higher education institutions, nonprofit organizations, governmental entities, and foreign institutions. The total budget for projects is capped at $100,000 over two years, with a maximum of $50,000 per year. The initiative also emphasizes the importance of sharing research data, especially from human subjects, through the National Database for Autism Research. Applications will be evaluated on significance, investigator qualifications, innovation, and approach, among other criteria. Key application deadlines and guidelines are specified, underscoring the need for adherence to NIH application protocols and ethical guidelines for human subject involvement. This funding opportunity reflects a critical investment in understanding and addressing ASD's complexities, aiming to improve outcomes for affected individuals and enhance service delivery systems.
    Similar Opportunities
    Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research on Autism Spectrum Disorders (ASD) through the R21 grant mechanism, aimed at elucidating the etiology, epidemiology, diagnosis, and service delivery methods related to ASD. This initiative encourages exploratory and developmental research without the need for preliminary data, allowing for innovative studies on genetic and environmental factors, early diagnosis, brain mechanisms, and cognitive skills. The total budget for projects is capped at $275,000 over two years, and applications are accepted from a wide range of eligible entities, including educational institutions and nonprofit organizations. Interested applicants must submit their proposals electronically via Grants.gov by November 16, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for any inquiries regarding the funding announcement.
    Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for research on Autism Spectrum Disorders (ASD) under the title "Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)." This initiative aims to support research that elucidates the etiology, epidemiology, diagnosis, and optimal service delivery methods related to ASD, encouraging applications from a diverse range of eligible organizations, including higher education institutions, non-profits, and tribal governments. The research projects may include clinical trials exploring biological or behavioral processes associated with ASD, with a focus on areas such as epidemiological studies, screening methods, and services research to enhance care for individuals with ASD. Applications are due by January 25, 2025, and interested parties can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries or assistance.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns," aimed at encouraging research into novel screening methods and therapeutic interventions for serious genetic and congenital conditions identified through newborn screening. This initiative, under the R03 Small Grant Program, supports small-scale projects lasting up to two years with a budget of up to $50,000 per year, focusing on developing robust screening technologies to enhance early detection and treatment of disorders, thereby minimizing long-term health consequences. The program is particularly important for addressing high-priority conditions where screening is not currently recommended, and it emphasizes inclusivity in research by inviting applications from a diverse range of organizations, including higher education institutions and community-based organizations. Interested applicants should note that the application deadline is November 16, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R03 Small Grant Program to enhance clinical trial readiness for rare diseases, disorders, and syndromes. This initiative aims to support research that identifies critical needs for advancing therapeutics or diagnostics in rare diseases, which are defined as affecting fewer than 200,000 individuals in the U.S., by developing better biomarkers, clinical outcome measures, and insights into the natural history of these conditions. The program emphasizes the importance of partnerships among researchers, industry, and patient advocacy groups to optimize clinical trial designs, while explicitly stating that applications should not propose clinical trials directly but focus on pre-trial research activities. The maximum funding available for each project is $100,000 over a two-year period, with applications due by October 17, 2024. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-160.html.
    NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03), which supports small clinical trials focused on basic experimental studies involving human participants. This funding opportunity aims to enhance understanding of fundamental phenomena without immediate application towards products or processes, aligning with the NICHD's mission in human development, behavior, and health. Grants are available for up to $50,000 in direct costs per year, with a maximum project duration of two years, and applications must be submitted by January 7, 2025. Interested applicants can find more information and application details at the NIH website or contact the NIH OER Webmaster at grantsinfo@nih.gov for assistance.
    NICHD Small Research Grant Program (R03 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03 Clinical Trial Required) to support clinical trials that align with the mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This grant program is designed to fund small research projects with a maximum budget of $50,000 in direct costs per year, for a duration of up to two years, focusing on areas such as human development, childhood development, and rehabilitation medicine. Eligible applicants include a diverse range of organizations, including higher education institutions, nonprofits, for-profits, and tribal governments, with all applications required to propose clinical trials and adhere to NIH submission guidelines. Interested parties should note that the application deadline is January 7, 2025, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further inquiries. More information can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PA-21-221.html.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), is offering a Small Research Grant Program (R03) aimed at fostering the next generation of researchers in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This program supports innovative projects that enhance understanding, diagnosis, treatment, and care strategies for AD/ADRD, while also promoting workforce diversity and addressing health disparities in this field. Grants of up to $100,000 for a duration of two years are available, with a total of 12 awards expected for fiscal year 2024, amounting to $1.8 million in funding. Interested applicants must be affiliated with eligible organizations and are encouraged to submit their applications by March 16, 2026, with inquiries directed to grantsinfo@nih.gov for further information.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for innovative research aimed at developing screening approaches and therapies for screenable disorders in newborns, designated as R21 - Clinical Trial Optional. This initiative encourages projects that focus on creating novel screening techniques and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening, particularly emphasizing early diagnosis and treatment to improve health outcomes. The program is part of NIH's commitment to advancing public health and reducing health disparities, with a funding ceiling of $275,000 available over a two-year period. Interested applicants, including a diverse range of institutions and organizations, must submit their proposals by November 16, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) to support small-scale research projects that can be completed in a short timeframe with limited resources. This program is designed to fund various types of research, including pilot studies, secondary data analysis, and the development of research methodologies, while explicitly excluding clinical trials. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and tribal governments, with each application allowed to request up to $50,000 per year for a project duration not exceeding two years. Interested parties should submit their applications electronically via Grants.gov by January 7, 2025, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for any inquiries regarding the funding announcement.
    Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) grant. This funding opportunity aims to support projects that address critical needs for clinical trial readiness in rare diseases, specifically by facilitating the development of biomarkers and clinical outcome measures essential for trial design. The initiative is particularly important for advancing research on diseases affecting fewer than 200,000 individuals in the U.S., enhancing the likelihood of successful clinical trials. Applicants can request up to $275,000 over two years, with a submission deadline of October 17, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-159.html.